New Collaboration to Understand Zantrene Cardioprotection Released 02 Mar 23
Latest announcements
Announcement summary
New Collaboration to Understand Zantrene Cardioprotection
- Race Initiates New Collaboration to Understand Zantrene Cardioprotection Mechanism
- Important step in understanding how Zantrene can protect the heart from chemotherapy-induced damage
- Collaboration will use state-of-the-art biochemical, cellular and mouse models of cardioprotection
- Program led by leading international cardio-oncologist Dr Brian Jensen of the McAllister Heart Institute, University of North Carolina at Chapel Hill, USA
Ask a question
Your question will be sent privately to Race Oncology. The company may choose to make this question public.
Investor Q&A's
Start the conversation
Ask Race Oncology a question about this announcement.